Pharmacy benefit management (PBM)

CVS planning ahead for Trump rebate rule

Photo: Bryan Bedder/Getty Images for CVS Pharmacy

Drug companies haven't pledged to lower their prices once the Trump administration finalizes a rule to overhaul the rebate system used by pharmacy benefit managers. CVS Health is asking drugmakers to at least not start charging more.

Driving the news: CVS Health has sent letters to 60 pharmaceutical companies asking them not to increase the net cost of their drugs — the price after factoring in rebates — in response to the Trump administration's rule.

PBMs are changing; drug prices aren't

Adapted from a Pew report; Chart: Axios Visuals
More stories loading.